Article Information
History
- June 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Matthew H V Byrne1,2,#,
- Fanourios Georgiades3,4,
- Alexander Light5,
- Catherine E Lovegrove1,2,
- Catherine Dominic6,
- Josephine Rahman7,
- Senthooran Kathiravelupillai8,
- Tobias Klatte9,
- Kasra Saeb-Parsy4,
- Rajeev Kumar1,
- Sarah Howles1,2,
- Grant D Stewart3,4,
- Ben Turney1,2,
- Oliver Wiseman4 and
- the COVID Stones Collaborative*
- 1Nuffield Department of Surgical Sciences, University of Oxford, UK
- 2Oxford University Hospitals NHS Foundation Trust, UK
- 3Department of Surgery, University of Cambridge, UK
- 4Cambridge University Hospitals NHS Foundation Trust, UK
- 5Department of Surgery and Cancer, Imperial College London, UK
- 6Barts and the London School of Medicine, Queen Mary University of London, UK
- 7University of Bristol, UK
- 8School of Clinical Medicine, University of Cambridge, UK
- 9Department of Urology, Charité - Universitätsmedizin Berlin, Germany
- ↵#Corresponding author
Name: Matthew Byrne, Email address: matthew.byrne{at}nds.ox.ac.uk, Full Institution address: Oxford University Hospitals NHS Foundation Trust, UK, Institution post code: OX3 7LE, Twitter: @mhvbyrne
Posted June 28, 2022.
Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study
